Genvor Inc
GNVR- Exchange
- OTC
- Industry
- Agricultural Production-Crops
- SEC CIK
- 0001792941
No open-market purchases or sales by Genvor Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Genvor Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Genvor Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pawlak Chad Lee Sr. | Chief Executive Officer | 7,000,000 | Apr 16, 2026 | 4 |
| Jaynes Jessee M | Chief Research Officer | 524,000 | Dec 5, 2025 | 1 |
| Yates Clayton Clopton | Director, 10% Owner | 400,000Indirect | Jun 23, 2025 | 0 |
| Miller Judith Selene | Chief Business Officer | 1,071,170Indirect | Mar 18, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.